Difference between revisions of "Amyloid"

Jump to navigation Jump to search
12 bytes added ,  16:06, 24 January 2011
Line 43: Line 43:
**Familial Mediterranean fever.<ref name=merck/>
**Familial Mediterranean fever.<ref name=merck/>
*Malignancy.
*Malignancy.
**Plasmacytoma.
**[[Plasmacytoma]].
***5-15% of patients with multiple myeloma develop amyloidosis<ref>{{Ref_PBoD|261}}</ref> - some say 10-20%.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref>
***5-15% of patients with multiple myeloma develop amyloidosis<ref>{{Ref_PBoD|261}}</ref> - some say 10-20%.<ref name=merck>Amyloidosis. Merck Manual. URL: [http://www.merck.com/mmpe/sec12/ch160/ch160a.html http://www.merck.com/mmpe/sec12/ch160/ch160a.html]. Accessed on: 3 December 2009.</ref>
**Medullary thyroid carcinoma.
**[[Medullary thyroid carcinoma]].
**Renal cell carcinoma.
**[[Renal cell carcinoma]].
*Many other conditions...
*Many other conditions...


48,830

edits

Navigation menu